eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Projected to grow at a CAGR of around 12%, eclinical solutions market is expected to witness significant growth by 2024 owing to the increasing demand for software solutions for clinical trials by the pharma and biopharma companies." 22 October 2018 - The global eclinical Solutions Market is anticipated to exceed USD 13 billion by 2024. The major growth driving factors include a rise in the R&D activities by various pharma and biopharma companies, growing application of software solutions in medical trials, rising government funding for promoting clinical research programs, increasing consumer base, and so on. In addition to this, rising outsourcing of medical trials to Contract Research Organization (CROs), growing medical research programs in various Asian countries along with the development of low-cost modules are also projected to boost the market growth. However, high implementation prices, the lack of skilled labor & awareness about clinical data sciences software are likely to hinder the growth of the market in the near future. The global market is divided into products and regions. The products sector includes Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (ECOA), Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Safety Solutions, Clinical Data Integration Platforms, Clinical Trial Management Systems (CTMS), and Electronic Trial Master File (e-tmf). The ECOA sector is projected to experience the maximum growth rate over the forecast period (from 2016 to 2024), while the CDMS and EDC sectors are anticipated to dominate the market through the year 2016. Browse Details of Report @ https://www.hexaresearch.com/research-report/eclinical-solutions-market
Regionally, the global eclinical solutions market is segregated as Latin America, North America, Asia-Pacific, Europe, and the Middle East & Africa. As of 2016, the North American market is expected to dominate the global market occupying the largest industry share. The major factor for this growth is the growing number of ongoing medical trials in the region. Some other factors include the rising government support for clinical trials, extensive Research & Development activities resulting in the production and launch of innovative products, and the increasing occurrences of lifestyle diseases. The APAC region is also likely to witness a rapid growth over the next few years. The rising participation of developing countries in the clinical trials is said to augment the market growth during the estimated years. The key companies operating in the global eclinical solutions market are Parexel International Corp.; ERT inc.; Oracle Corp.; BioClinica; DataTrak International Inc.; Medidata Solution Inc.; Merge Health Inc.; CRF Health Inc.; OmniComm Systems Inc.; and eclinical Solutions LLC. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcareindustry
Table of Content of eclinical Solutions Market Chapter 1. Methodology and Scope 1.1. Research methodology 1.2. Research scope & assumption 1.3. List of data sources Chapter 2. Executive Summary 2.1. eclinical Solutions Market - Industry Summary and Key Buying Criteria, 2016-2024 Chapter 3. eclinical Solutions Industry Outlook 3.1. Market segmentation 3.2. Market size and growth prospects, 2016-2024 3.3. eclinical Solutions: Market dynamics 3.3.1. Market driver analysis 3.3.1.1. Increasing externalization of clinical trial studies by the large biopharma and pharma companies 3.3.1.2. Presence of a strong range of products in pipeline 3.3.2. Market restraint analysis 3.3.2.1. Scarcity of skilled research professionals 3.3.2.2. Lack of recognition 3.4. eclinical solutions market: Industry trend analysis 3.5. eclinical solutions market: PESTEL Analysis 3.6. eclinical solutions industry analysis - Porter's Five Forces Model 3.7. eclinical solutions: Company market share analysis (%), 2016 3.8. Key opportunities prioritized Chapter 4. eclinical Solutions Product Outlook 4.1. eclinical Solutions Revenue Share (%) Analysis, by Product, 2016 & 2024 4.2. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 4.2.1. EDC and CDMS market revenue, by region, 2016 to 2024 (USD Million) 4.3. Clinical Trial Management Systems (CTMS) 4.3.1. CTMS market revenue, by region, 2016 to 2024 (USD Million) 4.4. Clinical Analytics Platforms 4.4.1. Market revenue, by region, 2016 to 2024 (USD Million) 4.5. Randomization and Trial Supply Management (RTSM) 4.5.1. RTSM market revenue, by region, 2016 to 2024 (USD Million) 4.6. Clinical Data Integration Platforms 4.6.1. Market revenue by region, 2016 to 2024 (USD Million)
4.7. Electronic Clinical Outcome Assessment (ECOA) 4.7.1. ECOA market revenue, by region, 2016 to 2024 (USD Million) 4.8. Safety Solutions 4.8.1. Market revenue, by region, 2016 to 2024 (USD Million) 4.9. Electronic Trial Master File (etmf) 4.9.1. etmf market revenue, by region, 2016 to 2024 (USD Million) Chapter 5. eclinical Solutions Delivery Mode Outlook 5.1. eclinical Solutions Revenue Share (%) Analysis, by Delivery Mode, 2016 & 2024 5.2. Web-hosted (on-demand) 5.2.1. Web-hosted (on-demand) market revenue, by region, 2016 to 2024 (USD Million) 5.3. Licensed Enterprise (on premise) 5.3.1. Licensed enterprise (on premise) market revenue, by region, 2016 to 2024 (USD Million) 5.4. Cloud-Based 5.4.1. Cloud-basedmarket revenue, by region, 2016 to 2024 (USD Million) Chapter 6. eclinical Solutions Clinical Trial Outlook 6.1. eclinical Solutions Revenue Share (%) Analysis, by Clinical Trial, 2016 & 2024 6.2. Phase I 6.2.1. Phase I market revenue, by region, 2016 to 2024 (USD Million) 6.3. Phase II 6.3.1. Phase II market revenue, by region, 2016 to 2024 (USD Million) 6.4. Phase III 6.4.1. Phase III market revenue, by region, 2016 to 2024 (USD Million) 6.5. Phase IV 6.5.1. Phase IV market revenue, by region, 2016 to 2024 (USD Million) Chapter 7. eclinical Solutions End-User Outlook 7.1. eclinical Solutions Revenue Share (%) Analysis, by End-User, 2016 & 2024 7.2. Hospitals 7.2.1. Hospitals market revenue, by region, 2016 to 2024 (USD Million) 7.3. CROs 7.3.1. CROs market revenue, by region, 2016 to 2024 (USD Million) 7.4. Others 7.4.1. Others market revenue, by region, 2016 to 2024 (USD Million) Chapter 8. eclinical Solutions Regional Outlook 8.1. eclinical Solutions Market Share (%) Analysis, by Region, 2016 & 2024 8.2. North America 8.2.1. U.S.
8.2.1.1. U.S. eclinical solutions market, by product, 2016-2024 (USD Million) 8.2.1.2. U.S. eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.2.1.3. U.S. eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.2.1.4. U.S. eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.2.2. Canada 8.2.2.1. Canada eclinical solutions market, by product, 2016-2024 (USD Million) 8.2.2.2. Canada eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.2.2.3. Canada eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.2.2.4. Canada eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.3. Europe 8.3.1. Germany 8.3.1.1. Germany eclinical solutions market, by product, 2016-2024 (USD Million) 8.3.1.2. GermanyeClinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.3.1.3. Germany eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.3.1.4. Germany eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.3.2. U.K. 8.3.2.1. U.K. eclinical solutions market, by product, 2016-2024 (USD Million) 8.3.2.2. U.K. eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.3.2.3. U.K. eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.3.2.4. U.K. eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.4. Asia Pacific 8.4.1. China 8.4.1.1. China eclinical solutions market, by product, 2016-2024 (USD Million) 8.4.1.2. China eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.4.1.3. China eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.4.1.4. China eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.4.2. India 8.4.2.1. India eclinical solutions market, by product, 2016-2024 (USD Million) 8.4.2.2. India eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.4.2.3. India eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.4.2.4. India eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.5. MEA 8.5.1. South Africa 8.5.1.1. South Africa eclinical solutions market, by product, 2016-2024 (USD Million) 8.5.1.2. South Africa eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.5.1.3. South Africa eclinical solutions market, by clinical trial, 2016-2024 (USD Million)
8.5.1.4. South Africa eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.5.2. Saudi Arabia 8.5.2.1. Saudi Arabia eclinical solutions market, by product, 2016-2024 (USD Million) 8.5.2.2. Saudi Arabia eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.5.2.3. Saudi Arabia eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.5.2.4. Saudi Arabia eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.6. Latin America 8.6.1. Brazil 8.6.1.1. Brazil eclinical solutions market, by product, 2016-2024 (USD Million) 8.6.1.2. Brazil eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.6.1.3. Brazil eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.6.1.4. Brazil eclinical solutions market, by end-user, 2016-2024 (USD Million) 8.6.2. Mexico 8.6.2.1. Mexico eclinical solutions market, by product, 2016-2024 (USD Million) 8.6.2.2. Mexico eclinical solutions market, by delivery mode, 2016-2024 (USD Million) 8.6.2.3. Mexico eclinical solutions market, by clinical trial, 2016-2024 (USD Million) 8.6.2.4. Mexico eclinical solutions market, by end-user, 2016-2024 (USD Million) Chapter 9. Competitive Landscape 9.1. Oracle Corporation 9.2. Medidata Solutions Inc. 9.3. Parexel International Corporation 9.4. BioClinica 9.5. Datatrak International Inc. 9.6. CRF Health 9.7. ERT 9.8. eclinical Solutions 9.9. Merge Healthcare Inc. 9.10. OmniComm Systems Inc.
About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - https://www.hexaresearch.com